Skip to main content

UBS Group AG

Position in NEO — Neogenomics Inc

CIK 1610520 ZURICH, V8

Position in NEO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,413,183
-$2,674,286 QoQ
Shares Held
190,456
-45.2% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Derivatives in NEO

reported options exposure · as of Mar 31, 2024
CallValue
$724,692
CallShares
46,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,683,964,878 across 46 Diagnostics & Research names. NEO ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,413,183 190,456
2025-12-31 $4,087,469 347,574
2025-09-30 $6,208,809 804,250
2025-06-30 $2,747,132 375,805
2025-03-31 $4,729,064 498,321
2024-12-31 $7,027,070 426,400
2024-09-30 $2,044,850 138,634
2024-06-30 $1,040,553 75,022
2024-03-31 $1,233,280 78,453
2024-03-31 $724,692 46,100
2023-12-31 $1,684,774 104,127
2023-09-30 $411,237 33,434
2023-06-30 $1,904,776 118,530
2023-03-31 $1,526,507 87,680
2022-12-31 $744,669 80,592
2022-09-30 $325,259 37,777
2022-06-30 $240,742 29,539
2022-03-31 $631,423 51,969
2021-12-31 $2,848,166 83,475
2021-09-30 $3,993,403 82,782
2021-06-30 $1,800,882 39,869
2021-03-31 $3,621,252 75,083
2020-12-31 $6,251,900 116,120
2020-09-30 $2,910,989 78,910
2020-06-30 $2,928,507 94,529
2020-03-31 $3,336,695 120,851